Dr. Reddy's Laboratories has reported total income of Rs.4850.8 crores during the period ended March 31, 2021 as compared to Rs.5012.4 crores during the period ended December 31, 2020. The company reported total income of Rs.4522.5 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.557.3 crores for the period ended March 31, 2021 as against net profit of Rs.27.9 crores for the period ended December 31, 2020. The company has posted net profit of Rs.781.1 crores for the period ended March 31, 2020.

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during the 12 months period ended March 31, 2021 as compared to Rs.18137.6 crores during the 12 months period ended March 31, 2020.

The company has posted net profit of Rs.1951.6 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.2026 crores for the 12 months period ended March 31, 2020.

The company has reported EPS of Rs.117.34 for the 12 months period ended March 31, 2021 as compared to Rs.121.99 for the 12 months period ended March 31, 2020.

Commenting on the results, G V Prasad, Co-Chairman & MD, said "In FY 21, we continued to grow across all our businesses, enhance productivity and strengthen our development pipeline. We are prioritizing our efforts to launch Sputnik V vaccine across India while working on the development and commercialization of several drugs for the treatment of mild to severe COVID 19 infections."